DSP Nifty Healthcare ETF

Benchmark: Nifty Healthcare TRI

View Basket

Total AUM

₹13.18 crores as of Dec 31, 2024

Age of Fund

11 months since Feb 01, 2024

Expense Ratio

0.21%
as of Jan 30, 2025

Exit Load

Nil

Goal of Investment

Capital Growth & Income

Ideal holding period

10 Years+

Portfolio

Current Allocation

as of Dec 31, 2024

Equity 99.96%
Debt / cash 0.04%

Equity
Debt / Cash

Top holdings

Sun Pharmaceutical Industries Limited

21.87%

Dr. Reddy's Laboratories Limited

9.1%

Cipla Limited

9.03%

Divi's Laboratories Limited

8.32%

Lupin Limited

6.1%

See all 20 holdings Top Group Holdings

Top holdings

No Data to display

Top holdings

TREPS / Reverse Repo Investments

0.04%

Cash & cash equivalents

-0%

Credit rating profile

Cash & Equivalent

100.00%

Instrument break-up

TREPS

100.00%

See 1 holding Top Group Holdings

Indicators

Tracking Error

0.03 %

Tracking Error (Abs.)

0.002 %

Historical Returns (As per SEBI format)as of with investment of₹10,000

	This fund		Nifty Healthcare TRI ^{^}		NIFTY 50 TRI ^#		Tracking difference
	CAGR	Current Value	CAGR	Current Value	CAGR	Current Value

Income distribution Cum Capital Withdrawal (IDCW) Distributed

Record Date	IDCW per unit	NAV Before	NAV After

Chart type:

Returns RangesStatistics

Invested Amount

₹

Invested period

Funds	Minimum	Median	Maximum	% times -ve returns	% times returns > 7%

Fund Details

Things to know before you invest

What is in DSP Nifty Healthcare ETF?

High Government's Healthcare Spending 2.5% of the budget has been forecasted by the Indian Government for healthcare spending as % of Gross Domestic Product (GDP) by FY25. More funds mean a healthier nation, which, also benefits the businesses in this sector.
Favorable Foreign Direct Investment (FDI) Flows in Healthcare 8% CAGR increase in Foreign Direct Investments (FDIs) in healthcare from FY13 to FY23. Within the broader level healthcare sector, FDI flows have increased in drugs & pharmaceuticals, hospitals & diagnostic centres, and medical & surgical appliances in India.
Remarkable Past performance The healthcare sector has the potential to provide reasonably high returns with events of short-term underperformance as well. However, since 2008, the Nifty Healthcare TRI has largely delivered relatively better CAGR of ~13% vs ~10% by Nifty 500 TRI.
Rising Insurance Penetration US$ 222 Billion reach expected in the Indian Insurance market by the year 2026. Many Indians have started to recognise the importance of owning health insurance, hence, the business opportunities have a potential to grow.
No Stock Selection Hassle Don't stress about picking individual stocks. The Healthcare Index covers it all from diversified themes like pharmaceuticals, hospitals, pathology, healthcare research analytics & technology. It adjusts or rebalances every 6 months i.e. semi-annually to represent the top 20 stocks (companies from healthcare sector) based on free float market cap from the Nifty 500 universe.

Who should invest in DSP Nifty Healthcare ETF?

Consider this fund if you
- If you value low-cost investing ideas.
- If you are okay with the returns not beating the respective Index the ETF is tracking.
- If you can stay invested for more than 5 years.
- If you can time the sector based on market dynamic.

Rethink before you invest

Expect short term return fluctuations, especially during periods of market volatility?.
Being a single sector based fund, DSP Nifty Healthcare ETF comes with high risk as well.

Fund managers:

Anil Ghelani

Managing Since February 2024

arrow_forwardSee funds managed by him

Managing Since February 2024

arrow_forwardSee funds managed by him

Diipesh Shah

Managing Since February 2024

arrow_forwardSee funds managed by him

Managing Since February 2024

arrow_forwardSee funds managed by him

Anil has been working with DSP Group since 2003 and is currently Head of Passive Investments & Products. Previously, he served as the Business Head & Chief Investment Officer at DSP Pension Fund Managers and prior to that leading the Risk and Quantitative Analysis team at DSP Mutual Fund responsible for monitoring of portfolio risk and buy-side credit research on companies across various sectors.
He also worked at IL&FS Asset Management Company and at S.R. Batliboi a member firm of EY. He is currently serving in volunteer capacity as a Director and Vice Chairman of the CFA Society India.
Anil is a CFA Charter Holder (CFA Institute USA), Chartered Accountant (ICAI India) and holds a Bachelor of Commerce degree (University of Mumbai).

Sr. No.	Scheme Name	Managing since	Period
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement Different plans shall have a different expense structure. The performance details provided herein are of regular plan. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Sr. No.

Scheme Name

Managing since

Period

1 Years

3 Years

5 Years

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Diipesh has a total work experience of Over 20 years. He is working with DSP from September 2019 as a Dealer for ETF and Passive Investments. Now he is also Fund Manager of various schemes of DSP Mutual Fund.
Diipesh has also worked with JM Financial Institutional Broking Limited, Centrum Boking Limited, IDFC Securities Limited and Kotak Securities Limited as Institutional Equity Sales Trading.
He is a Chartered Accountant (ICAI India) and also holds a Bachelor of Commerce Degree.

Sr. No.	Scheme Name	Managing since	Period
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement Different plans shall have a different expense structure. The performance details provided herein are of regular plan. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Sr. No.

Scheme Name

Managing since

Period

1 Years

3 Years

5 Years

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Scheme return (%)

Benchmark return (%)

Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement

Different plans shall have a different expense structure. The performance details provided herein are of regular plan.

Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments

Investment Objective

The Scheme seeks to provide returns that, before expenses, correspond to the total return of the underlying index (Nifty Healthcare TRI), subject to tracking errors.
There is no assurance or guarantee that the investment objective of the scheme will be achieved.

Fund Type

Exchange Traded Fund – Thematic

An open ended scheme replicating/ tracking Nifty Healthcare Index.

Riskometer

Level of Risk in the Scheme

View details

Other Information

NSE/BSE Symbol HEALTHADD
BSE Script Code 544109
ISIN INF740KA1UF4
Bloomberg Code DHEALTH
Minimum Investment Through Stock Exchange - 1 Unit & in multiples thereof.

Fund Documents

KIM and Applications

NSE Disclaimer: It is to be distinctly understood that the permission given by NSE should not in any way be deemed or construed that the Scheme Information Document has been cleared or approved by NSE nor does it certify the correctness or completeness of any of the contents of the Draft Scheme Information Document. The investors are advised to refer to the Scheme Information Document for the full text of the 'Disclaimer Clause of NSE'

BSE Disclaimer: It is to be distinctly understood that the permission given by BSE Limited should not in any way be deemed or construed that the SID has been cleared or approved by BSE Limited nor does it certify the correctness or completeness of any of the contents of the SID. The investors are advised to refer to the SID for the full text of the 'Disclaimer clause of the BSE Limited'.

Name	% of Net Assets
Sun Pharmaceutical Industries Limited	21.87%
Dr. Reddy's Laboratories Limited	9.10%
Cipla Limited	9.03%
Divi's Laboratories Limited	8.32%
Lupin Limited	6.10%
Aurobindo Pharma Limited	4.00%
Torrent Pharmaceuticals Limited	3.39%
Alkem Laboratories Limited	3.21%
Zydus Lifesciences Limited	2.61%
Glenmark Pharmaceuticals Limited	2.60%
Laurus Labs Limited	2.54%
IPCA Laboratories Limited	2.47%
Biocon Limited	1.76%
Abbott India Limited	1.67%
Granules India Limited	0.92%

Name

% of Net Assets

Sun Pharmaceutical Industries Limited

21.87%

Dr. Reddy's Laboratories Limited

9.10%

Cipla Limited

9.03%

Divi's Laboratories Limited

8.32%

Lupin Limited

6.10%

Aurobindo Pharma Limited

4.00%

Torrent Pharmaceuticals Limited

3.39%

Alkem Laboratories Limited

3.21%

Zydus Lifesciences Limited

2.61%

Glenmark Pharmaceuticals Limited

2.60%

Laurus Labs Limited

2.54%

IPCA Laboratories Limited

2.47%

Biocon Limited

1.76%

Abbott India Limited

1.67%

Granules India Limited

0.92%

Name	% of Net Assets
Max Healthcare Institute Limited	8.99%
Apollo Hospitals Enterprise Limited	7.93%
Syngene International Limited	1.67%
Dr. Lal Path Labs Ltd.	1.20%
Metropolis Healthcare Limited	0.58%

Name

% of Net Assets

Max Healthcare Institute Limited

8.99%

Apollo Hospitals Enterprise Limited

7.93%

Syngene International Limited

1.67%

Dr. Lal Path Labs Ltd.

1.20%

Metropolis Healthcare Limited

0.58%

Name	% of Net Assets
TREPS / Reverse Repo Investments	0.04%

Email ID
Mobile no.

Email ID	ABH************[email protected]
Mobile no.	******6665

Email ID

ABH************[email protected]

Mobile no.

******6665

	Folio no.	Email ID	Mobile no.
	70****76	abh************[email protected]	******6665
	42***02	abh************[email protected]	******6665

Folio no.

Email ID

Mobile no.

70****76

abh************[email protected]

******6665

42***02

abh************[email protected]

******6665